Martin P. Sutter - Jun 6, 2023 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Director
Signature: /s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol: BVS
Transactions as of: Jun 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/13/2023, 05:12 PM
Previous filing: Dec 27, 2022
Next filing: Jun 11, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+16.6K	+142.29%	$0.00	28.3K	Jun 6, 2023	Direct
holding	BVS	Class A Common Stock						13M	Jun 6, 2023	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-16.6K	-100%	$0.00^*	0	Jun 6, 2023	Class A Common Stock	16.6K		Direct	F2, F3
transaction	BVS	Restricted Stock Units	Award	$0	+30.4K		$0.00	30.4K	Jun 7, 2023	Class A Common Stock	30.4K		Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 12,096,702 shares of Class A Common Stock held by EW Healthcare Partners Acquisition Fund, L.P. ("Essex Stockholder") and 924,622 shares of Class A Common Stock held by White Pine Medical, LLC ("White Pine"). EW Healthcare Partners Acquisition Fund UGP, LLC ("General Partner") is the general partner of EW Healthcare Partners Acquisition Fund GP, L.P., which is the general partner of Essex Stockholder, which is the managing member of White Pine. Messrs. Sutter, Vainio, Eastman, and Barry (collectively, the "Managers") are the managers of the General Partner. The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F3	The RSUs vested on June 6, 2023.
F4	The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.